| Literature DB >> 35883842 |
Asma Saidi1,2, Leila Hambaba1, Mohamed Sabri Bensaad1,3, Mohamed Akram Melakhessou1, Chawki Bensouici4, Nouicer Ferhat5, Mohamed Amine Kahoul6, Mahmoud Helal7, Rokayya Sami8, Saif A Alharthy9,10, Roua S Baty11, Nouf H Alsubhi12, Ghadeer I Alrefaei13, Abeer Elhakem14, Sarah Alharthi15, Fahmy G Elsaid16,17, Ali A Shati16.
Abstract
The perennial aromatic plant Ruta tuberculata Forssk (Rutaceae) has been traditionally used by Mediterranean peoples as folk medicine against several types of disease to treat diverse illness. The objective of this work is to evaluate the in vitro and in vivo pharmacological activities of the aqueous (RAE) and methanolic (MeOH) 80% (RME) extracts of Algerian R. tuberculata aerial parts. Antioxidant potential, neuro-protective and anti-arthritic activities were investigated in vitro using six antioxidant approaches and by determining acetyl-cholinesterase and bovine albumin denaturation inhibitory capacities, respectively. Furthermore, in vivo anti-ulcer and anti-inflammatory activities were evaluated on EtOH-induced gastric mucosal damage and carrageenan-induced paw edema models in mice. Moreover, bio-compounds' contents were also quantified using spectrophotometric and cLC-DAD methods. Both in vivo and in vitro investigations showed remarkable antioxidant activity of Ruta tuberculata Forssk, while methanolic extract (RME) of Ruta tuberculata Forssk exhibited more significant neuro-protective and anti-inflammatory effects. However, the antiulcer activity was more pronounced with RAE of R. tuberculata, which suggests that this plant can be considered as a natural resource of potent bioactive compounds that may act as antioxidant and anti-inflammatory agents, which underlines the importance of incorporating them in therapies in order to treat various diseases linked to oxidative stress, and they may also provide crucial data for the development of new anticholinesterase drugs to improve neurodegenerative diseases, such as Alzheimer's.Entities:
Keywords: Rutatuberculata; anti-cholinesterase; anti-inflammatory; anti-ulcer; antioxidant; cLC-DAD analysis
Year: 2022 PMID: 35883842 PMCID: PMC9312153 DOI: 10.3390/antiox11071351
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1LC−DAD chromatogram of secondary metabolites from R. tuberculata aqueous extract. (A) Global chromatograms detected at four wavelengths: (B) at 254 nm, (C) at 280 nm (D), at 325 nm and (E) at 360 nm.
Figure 2LC−DAD chromatogram of secondary metabolites from R. tuberculata methanolic extract. (A) Global chromatograms detected at four wavelengths (B) at 254 nm, (C), at 280 nm (D), at 325 nm and (E) at 360 nm.
Quantification of phenolic compounds in R. tuberculata extracts using cLC-DAD system.
| N° | Compound | cLC-DAD | |||
|---|---|---|---|---|---|
| RT | UV | RAE | RME | ||
| Extracted Amount (mg/100 g d.E) | |||||
|
|
| 10.37 | 280 | 264.16 | 24.53 |
|
|
| 14.12 | 280 | 7.00 | 16.75 |
|
|
| Nt | Nt | Nt | Nt |
|
|
| Nt | Nt | Nt | Nt |
|
|
| 14.80 | 254 | 21.32 | 10.38 |
|
|
| 16.68 | 280 | 11.19 | 10.40 |
|
|
| 15.62 | 325 | 4.14 | 27.15 |
|
|
| Nt | Nt | Nt | Nt |
|
|
| 17.32 | 280 | 2.41 | 2.93 |
|
|
| 17.94 | 325 | 10.28 | 3.19 |
|
|
| 19.14 | 360 | 31.67 | 58.31 |
|
|
| 19.51 | 360 | 2624.82 | 5368.64 |
|
|
| 19.96 | 280 | 701.62 | 700.00 |
|
|
| 18.02 | 280 | 20.21 | 69.97 |
|
|
| 20. 81 | 360 | 4.50 | 25.86 |
|
|
| Nt | Nt | Nt | Nt |
|
|
| 20. 89 | 280 | 25.38 | 100.99 |
|
|
| 21.36 | 280 | 112.07 | 131.87 |
RT: retention time; Nt: not tested.
Antioxidant activities of the polar extracts from R. tuberculata aerial parts.
| Extract/ | Radical Scavenging | Lipid Peroxidation | Reducing Power | Total Antioxidant Capacity (TAC) | ||
|---|---|---|---|---|---|---|
| DPPH | ABT’S | FRAP | CUPRAC | |||
| IC50 (μg/mL) | A0.5 (μg/mL) | AAE (mg/g E) | ||||
|
| 74,87 ± 1.1 ns,a,b,d | 143.54 ± 1.0 d | 254. 58 ± 1.7 d | 132.92 ± 0.9 ns,d | 196.9 ± 0.8 a,d | 369.57 ± 1.0 d |
|
| 53.78 ± 0.5 ns,b,d | 80.72 ± 0.9 d | 153.18 ± 0.06 d | 132.71 ± 1.1 ns,d | 211.34 ± 2.2 d | 135.8 ± 0.02 |
|
| 49.77± 0.1 a,c,d | 1.55 ± 0.26 d | 1.24 ± 0.00 ns,d | >50 | 9.62 ± 0.9 d | Nt |
|
| 15.74 ± 0.5 c,d | 7.54 ± 0.7 d | 1.26 ± 0.00 ns,d | 8.41 ± 0.7 a,d | 3.64 ± 0.2 d | Nt |
|
| 26.38 ± 0.5 a,c,d | Nt | Nt | 9.01 ± 1.5 a,d | Nt | Nt |
|
| 53.03 ± 0.0 b,c,d | Nt | Nt | 6.91 ± 0.0 a,d | Nt | Nt |
|
| 60.77 ± 0.0 a,d | Nt | Nt | 24.01 ± 0.0 d | Nt | Nt |
Values are expressed as means ± SD (n = 3) and are presented as ascorbic acid equivalent, IC50 and/or A0.5 values. Mean values followed by different letters are significantly different (based on one-way ANOVA followed by Tukey’s multiple comparison tests) ns is not significant, Level of Significance a p < 0.05, b p < 0.01, c p < 0.001, d p < 0.0001); nt: not tested.
Inhibitory effect of R. tuberculata extracts on acetyl-cholinesterase and bovine albumin denaturation assays.
| Extract/ | AChE Inhibition Assay | Bovine Albumin Denaturation Assay | ||
|---|---|---|---|---|
| Max Inhibition (%) | IC50 (μg/mL) | Max Inhibition (%) | IC50 (μg/mL) | |
|
| 89.7 ± 1.5 | 51.08 ± 1.6 a,d | 57.9 ± 0.04 | 212.27 ± 0.04 b,c |
|
| 82.3 ± 1.4 | 56.7 ± 0.97 a,d | 48.1 ± 0.02 | >400 |
|
| 94.7 ± 0.3 | 6.27 ± 1.1 | Nt | Nt |
|
| Nt | Nt | 84.9 ± 0.8 | 115.76 ± 0.8 |
Values are expressed as means ± SD (n = 3). Mean values followed by different letters are significantly different (based on one-way ANOVA followed by Tukey’s multiple comparison tests). Level of Significance a p < 0.05, b p < 0.01, c p < 0.001, d p < 0.0001); Nt: not tested.
Figure 3Effect of R. tuberculata extracts on albumin denaturation. Values were expressed as mean ± SD (n = 5). Mean values followed by different letters are significantly different (based on one-way ANOVA followed by Tukey’s multiple comparison tests. Level of Significance: a p < 0.05, b p < 0.01, c p < 0.001, d p < 0.0001).
Anti-inflammatory activity of R. tuberculata polar extracts and indomethacin on Carrageenan-induced paw edema in mice.
| Treatment | Dose | ∆ Paw Diameter (mm) | |||||
|---|---|---|---|---|---|---|---|
| Before Treatment | After Treatment | ||||||
| 1 h | 2 h | 3 h | 4 h | 5 h | |||
|
|
| 1.65 ± 0.02 | 2.82 ± 0.03 | 3.24 ± 0.03 | 3.68 ± 0.06 | 4.02 ± 0.01 | 4.37 ± 0.04 |
|
| 20 | 1.62 ± 0.09 ns | 2,01 ± 0,07 c (28.73%) | 2,00 ± 0,06 c (38.36%) | 1,86 ± 0,04 d (49.64%) | 1,76 ± 0,02 d (56.28%) | 1.73 ± 0.04 d (60.37%) |
|
| 200 | 1.67 ± 0.16 ns | 2.44 ± 0.12 b | 2.24 ± 0.11 c (30.84%) | 2.06 ± 0.12 c,a (43.98%) | 1.99 ± 0.11 d,b (50.39%) | 1.87 ± 0.07 d (57.16%) |
|
| 400 | 1.65 ± 0.11 ns | 2.37 ± 0.05 b | 2.19 ± 0.06 c | 2.05 ± 0.04 c,a | 1.96 ± 0.06 d,b | 1.73 ± 0.02 d |
|
| 200 | 1.70 ± 0.07 ns | 2,43 ± 0.10 b | 2,20 ± 0.17 c | 2,17 ± 0.18 c,a | 1.99 ± 0.17 d,b(50.60%) | 1.77 ± 0.02 d |
|
| 400 | 1.66 ± 0.11 ns | 2.35 ± 0.10 b | 2.13 ± 0.11 c | 2.02 ± 0.07 c,a | 1.95 ± 0.08 d,b | 1.67 ± 0.04 d |
Carrageenan-IPE: Carrageenan-induced paw edema. Percentage inhibition of paw edema was expressed as mean ± SEM (n = 6). Mean values followed by different letters are significantly different (based on one-way ANOVA followed by Tukey’s multiple comparison tests, ns is no significant, Level of Significance: a p < 0.05, b p < 0.01, c p < 0.001, d p < 0.0001) compared to control groups.
Figure 4Macroscopic morphology of mice stomachs in ethanol-induced gastric damage model (H&E stain × 100). (A) Normal control (B) ethanol-control, (C) omeprazole (20 mg/kg), (D) RAE (200 mg/kg), (E) RAE (400 mg/kg), (F) RME (200 mg/kg), (G) RME (400 mg/kg).
Anti-ulcerogenic activity of R. tuberculata polar extracts on ethanol-induced ulcers in mice.
| Groups | Treatment | Dose (mg/kg) | Ulcer Index (UI) | PP (%) |
|---|---|---|---|---|
|
| EtOH-IGU Control | Normal saline (10 mL/kg) | 4.7 ± 0.24 | 0 |
|
| Omeprazole | 20 | 0.9 ± 0.1 d | 80.9 ± 0.7 |
|
| RAE | 200 | 1.9 ± 0.12 c,b,a | 59.6 ± 0.63 c,a |
|
| RAE | 400 | 0.9 ± 0.05 d | 81.3 ± 0.6 ns,a |
|
| RME | 200 | 2.2 ± 0.13 b,c,a | 53.2 ± 1.3 c,a |
|
| RME | 400 | 1.1 ± 0.1 d | 76.6 ± 1.0 b |
EtOH-IGU: ethanol-induced gastric ulcers. Ulcer index (UI) and preventive percentage (PP) were expressed as mean ± SEM (n = 6). Mean values followed by different letters are significantly different (based on one-way ANOVA followed by Tukey’s multiple comparison tests, Level of Significance a p < 0.05, b p < 0.01, c p < 0.001, d p < 0.0001).
Figure 5Histological examination of mice paws tissue in carrageenan-induced paw edema model (H&E stain, Magnification × 100).KR: Keratin. EP: epidermal layer. DE: dermal layer. FP: fatty part. SM: Striated muscle. (A) Normal control shows normal keratin (KR), normal epidermal and sub epidermal architecture. (B) Carrageenan-induced paw edema group shows massive inflammatory cells infiltration (ICI), hyper keratotic skin HKS, Sub epidermal edema (SEE) and several vascular congestions. Pre-treatment with Indomethacin (C) or (D) RAE and RME at dose of 400 mg/kg (E,G) prevent significantly the carrageenan-induced paw edema with no signs of acute skin inflammation. Treated groups with RAE (E) and RME (F) at 200 mg/kg show few cell infiltration and minor vascular congestions which suggest onset of inflammatory response phenomena.
Figure 6Histological examination of mice stomach tissues in Ethanol-induced gastric damage model (H&E stain × 100). (A) Normal control shows normal morphology of mucosal epithelium (B) ethanol-control, (C) omeprazole (20 mg/kg), (D) RAE extract (200 mg/kg), (E) RAE extract (400 mg/kg), (F) RME extract (200 mg/kg), (G) RME extract (400 mg/kg). CR: corpus. FP: fatty part. ML: muscle layer.